Company intelligence / Profile preview

Biometrik Riset Indonesia

Depok, West Java, Indonesiabiometrikriset.com ↗

Ownership: Private
Development stage: Other

Overview

Biometrik Riset Indonesia is a leading Indonesian CRO specializing in bioequivalence and clinical research services. The company has conducted over 100+ bioequivalence studies supporting generic drug approvals. Recent published results include successful demonstration of bioequivalence for candesartan tablets and ongoing work with gabapentin capsules[5][10].

Therapeutic areas: CardiovascularNeurology
Modalities: Small molecule (focus on generic drug bioequivalence studies)Device (for clinical research, if applicable)
Industry: Contract Research Organization

Partnerships

Collaborates with pharmaceutical manufacturers such as PT Hexpharm Jaya Laboratories and PT Takeda Indonesia for BE studies

Beyond the preview

Go deeper on Biometrik Riset Indonesia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biometrik Riset Indonesia.

Explore the full profile